Table 2.
Distribution of mycoplasma and high-risk human papillomavirus (hrHPV) in the study population in total and by HIV status.
| All participants | HIV positive | HIV negative | p-Value | |
|---|---|---|---|---|
| M. genitalium | n = 142 | n = 101 | n = 41 | |
| Prevalence | 43 (30.3) | 28 (27.7) | 15 (36.6) | 0.31 |
| Persistence | 23 (16.2) | 23 (22.7) | 0 (0) | <0.001 |
| M. hominis | n = 194 | n = 139 | n = 55 | |
| Prevalence | 87 (44.8) | 48 (34.5) | 39 (70.1) | <0.001 |
| Persistence | 59 (30.4) | 58 (41.7) | 1 (1.7) | <0.001 |
| hrHPV | n = 194 | n = 139 | n = 55 | |
| Prevalence | 77 (39.7) | 63 (45.3) | 14 (25.4) | 0.01 |
| Persistence | 60 (30.9) | 50 (35.9) | 10 (18.2) | 0.01 |